SLC1A3 and amyotrophic lateral sclerosis: In humans, prior research has shown GLAST protein loss in the motor cortex and spinal cord of ALS patients, along with abnormal glutamate metabolism (Bristol and Rothstein, 1996; Rothstein et al., 1995; Sugiyama et al., 2017).